Ramantamig

Approval Year

Name

Type

Language

H-gamma1 heavy chain anti-CD3E fused to a scFvkh anti-GPRC5D (1-721) [Hgamma1 heavy chain anti-CD3E Homo sapiens (1-450) [VH (Homo sapiens IGHV6-1*01 (88.1%) -(IGHD) -IGHJ4*01 (100%), CDR-IMGT [10.9.10] (26-35.53-61.100-109)) (1-120)-Homo sapiens IGHG1*0

Preferred Name

English

Ramantamig

Official Name

English

Immunoglobulin G1, trispecific, [237-alanine,238-alanine,268-serine,369-serine,371-alanine,410-valine,438-arginine,439-phenylalanine], anti-(human CD3 antigen ?-chain) (human monoclonal BGCB491 ?1-chain) fusion protein with peptide linker (GGGGS)4 fusion

Common Name

English

immunoglobulin (H-gamma1-scFvkh_L-lambda2)_scFvkh-G1(h-CH2-CH3), anti-[Homo sapiens CD3E (CD3 epsilon, Leu-4)], anti-[Homo sapiens GPRC5D (G protein-coupled receptor class C group 5 member D)] and anti-[Homo sapiens TNFRSF17 (tumor necrosis factor (TNF)

Common Name

English

ramantamig [INN]

Common Name

English

Code System Code Type Description

INN

13340

Created by admin on Wed Apr 02 19:41:36 GMT 2025 , Edited by admin on Wed Apr 02 19:41:36 GMT 2025

PRIMARY

CAS

2988886-91-3

Created by admin on Wed Apr 02 19:41:36 GMT 2025 , Edited by admin on Wed Apr 02 19:41:36 GMT 2025

PRIMARY

FDA UNII

L97FGF546Q

Created by admin on Wed Apr 02 19:41:36 GMT 2025 , Edited by admin on Wed Apr 02 19:41:36 GMT 2025

PRIMARY

ACTIVE MOIETY


					L97FGF546Q

Ramantamig